¼¼°èÀÇ ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : Á¦Ç°º°, ½Ã¼úº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÎ¹® ¿¹Ãø(2024-2030³â)
Oculoplastic Surgery Market Size, Share & Trends Analysis Report By Product (Instruments, Implants & Grafts, Equipment), By Procedure (Eyelid Surgery, Face Lift, Orbital Surgery), By End-use, By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå
:
1493238
¸®¼Ä¡»ç
:
Grand View Research, Inc.
¹ßÇàÀÏ
:
2024³â 05¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 172 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :
Grand View ResearchÀÇ ÃֽŠº¸°í¼¿¡ µû¸£¸é, ¾È°ú ¼ºÇü ¼ö¼ú ¼¼°è ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 140¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È CAGRÀº 6.05%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ½ÃÀåÀº ÁÖ·Î ³ëÀÎ Àα¸ Áõ°¡, ¾È°ú ¼ºÇü ¼ö¼ú ¼ö¼ú Áõ°¡, ¸ÞµðÄà ¿¡½ºÅׯ½ ¾÷°èÀÇ ±â¼ú Áøº¸¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ȯÀÚÀÇ ÀÇ½Ä Áõ°¡¿Í °¡Ã³ºÐ ¼Òµæ Áõ°¡µµ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. °¡Ã³ºÐ ¼Òµæ Áõ°¡, »ýȰ ¼öÁØ, ¼Ò¼È ¹Ìµð¾î ¿µÇâ·Â, »ç¶÷µé ÀÇ½Ä µîÀÇ ¿äÀÎÀº ¼ºÀå¿¡ ÁÁÀº ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¹Ì±¹ ¾È¸éÇü¼º¿Ü°úÇÐȸ(AAFPRS)°¡ ½Ç½ÃÇÑ Á¶»ç°á°ú¿¡ µû¸£¸é ¼Ò¼È¹Ìµð¾î´Â ¹Ì¿ë, ƯÈ÷ ¼ÒºñÀÚÀÇ ÀÚ±âÀνİú ÀÚ±âÅõ¿µ ¹æ½Ä¿¡ »ó´çÇÑ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. Á¶»ç°á°ú¿¡¼´Â ¾È¸éÇü¼º ¿Ü°úÀÇÀÇ 55%°¡ 2017³â ¼¿Ä« »çÁø¿¡¼ ´õ Àß º¸ÀÌ°í ½Í´Ù´Â È¯ÀÚÀÇ »ó´ãÀ» ¹Þ°í ÀÖ¾î Àü³âº¸´Ù 13% Áõ°¡Çϰí ÀÖ´Ù°í °Á¶Çß½À´Ï´Ù.
½ÃÀå¿¡¼ ÀÔ¼öÇÒ ¼ö ÀÖ´Â ±¤¹üÀ§ÇÑ ¾È°ú ¼ºÇü ¼ö¼ú·Î ÇÕ¸®ÀûÀÎ °¡°Ý°ú ½ÇÇö°¡´É¼ºÀ¸·Î ÀÎÇØ ´õ ¸¹Àº »ç¶÷µéÀÌ ±×·¯ÇÑ Ä¡·á¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ÀÇ·áÅõ¾î¸®Áò Áõ°¡¿Í »óȯÁ¤Ã¥ÀÇ °³¼±µµ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á °ü±¤ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È »ó´çÇÑ ¼ºÀåÀÌ ¿¹»óµÇ¸ç, ÀÌ´Â ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå Àüü¿¡ ÁÁÀº Àç·á°¡ µÉ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.
¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- À¯¸®ÇÑ »óȯ Á¤Ã¥, ÁÖ¿ä ±â¾÷ÀÇ Á¸Àç, Á¤ºÎÀÇ Áö¿øÃ¥À¸·Î ºÏ¹Ì´Â 2023³â ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
- ¼ú½Äº°·Î´Â ´«²¨Ç® ºÎ¹®ÀÌ ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÏ°í ¿¹Ãø ±â°£ µ¿¾È¿¡µµ ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
- ´«½ç ¸®ÇÁÆ®¿Í À̸¶ ¸®ÇÁÆ® ºÐ¾ß´Â ÀÌ ¼ö¼úÀÇ Ã¤¿ë·üÀÌ ³ô±â ¶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼ºÀåÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
- ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â Bausch + Lomb, Carl Zeiss Meditec AG, Stryker, Integra LifeSciences Corporation µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ È¸»çµéÀº ÷´Ü ¼ºñ½º¸¦ µµÀÔÇϱâ À§ÇØ ½ÅÁ¦Ç° ¹ßÇ¥¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- ½ÃÀå ±âȸ ºÐ¼®
- ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå ºÐ¼® µµ±¸
- ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
- PESTEL ºÐ¼®
Á¦4Àå ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå : Á¦Ç°ÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå : Á¦Ç° º¯µ¿ ºÐ¼®
- Á¦Ç°º° ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå Àü¸Á
- 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
- ±â±â
- ÀÓÇöõÆ®¿Í À̽Ä
- ÀåÄ¡
Á¦5Àå ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå : ½Ã¼úÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå : ½Ã¼ú º¯µ¿ ºÐ¼®
- ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀåÀÇ ½Ã¼úº° Àü¸Á
- 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
- ´«²¨Ç® ¼ö¼ú
- ÆäÀ̽º ¸®ÇÁÆ®
- ´«½ç ¸®ÇÁÆ®/À̸¶ ¸®ÇÁÆ®
- ¼Ò¾Æ¾È Çü¼º ¿Ü°ú ¼ö¼ú
- ¾È°ú ¼ö¼ú
Á¦6Àå ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå : ÃÖÁ¾ ¿ëµµÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå : ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®
- ÃÖÁ¾ ¿ëµµº° ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå Àü¸Á
- 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× Æ®·»µå ºÐ¼®
- º´¿ø ¹× Áø·á¼Ò
- ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
Á¦7Àå ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå :Áö¿ª ÃßÁ¤ ¹× µ¿Ç⠺м®
- Áö¿ª ´ë½Ãº¸µå
- Áö¿ªº° ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå º¯µ¿ ºÐ¼®
- ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå : Á¦Ç°, ½Ã¼ú, Àç·á Á¦Ç°º° Áö¿ª ÃßÁ¤ ¹× µ¿Ç⠺м®
- 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× Æ®·»µå ºÐ¼®
- ºÏ¹Ì
- ºÏ¹Ì ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
- ¹Ì±¹
- ij³ª´Ù
- À¯·´
- À¯·´ ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- µ§¸¶Å©
- ½º¿þµ§
- ³ë¸£¿þÀÌ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
- ÀϺ»
- Áß±¹
- Àεµ
- Çѱ¹
- È£ÁÖ
- ű¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ¾Æ¸£ÇîÆ¼³ª
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
- ³²¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- Äí¿þÀÌÆ®
Á¦8Àå °æÀï ±¸µµ
- ½ÃÀå ÁøÃâ±â¾÷ÀÇ ºÐ·ù
- ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
- Surgical Holdings
- Matrix Surgical USA
- Integra LifeSciences Corporation
- Stryker
- FCI
- Bolton Surgical Ltd.
- RUMEX International Co.
- BVI Medical.
- Carl Zeiss Meditec AG
- Bausch Lomb
JHS
¿µ¹® ¸ñÂ÷
Oculoplastic Surgery Market Growth & Trends:
The global oculoplastic surgery market size is expected to reach USD 14.02 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to register a 6.05% CAGR over the forecast period. The market is primarily driven by the rising geriatric population, increasing number of oculoplastic surgical procedures, and technological advancements in the medical aesthetics industry. Furthermore, increasing patient awareness and rising disposable income are also fueling the growth. Factors such as the rising disposable income, standard of living, social media influence, and awareness among people are anticipated to bode well for the growth.
According to the results from a survey conducted by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), social media has massive impact on aesthetics, especially in the way consumers perceive and project themselves. The survey results highlighted that 55% of facial plastic surgeons consulted patients who wanted to look better in selfies in 2017, showing a 13% increase from the previous year.
With a wide range of oculoplastic surgery procedures available in the market, more people are willing to undergo such treatment due their affordability and feasibility. Furthermore, rising medical tourism and better reimbursement policies are also boosting the market growth. The medical tourism market is anticipated to witness significant growth over the forecast period, which is expected to bode well for the overall market for oculoplastic surgery.
Oculoplastic Surgery Market Report Highlights:
- North America accounted for the largest market share in 2023, owing to the presence of favorable reimbursement policies, presence of key players, and supportive government initiatives
- By procedure, eyelid segment accounted for the largest market share and is expected to maintain its dominance during the forecast period.
- Browlift and forehead lift segment is expected to register the fastest growth during the forecast period owing to high adoption of this surgery
- Some of the key companies in the oculoplastic surgery market are Bausch + Lomb, Carl Zeiss Meditec AG, Stryker, and Integra LifeSciences Corporation. These players are focusing on new product launches to introduce advanced services
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Oculoplastic Surgery Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Related/ Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Advancements in technology
- 3.2.1.2. Rising awareness regarding oculoplastic surgery
- 3.2.1.3. Increasing number of geriatric population
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High costs associated with surgery
- 3.2.2.2. Potential risks and complications associated with the procedure
- 3.2.3. Market Opportunity Analysis
- 3.2.3.1. Growth potential in emerging economies
- 3.3. Oculoplastic Surgery Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal Landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
Chapter 4. Oculoplastic Surgery Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Oculoplastic Surgery Market: Product Movement Analysis
- 4.3. Oculoplastic Surgery Market by Product Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Instruments
- 4.5.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.1.1. Forceps
- 4.5.1.1.1. Forceps Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.1.2. Knife Handles and Blades
- 4.5.1.2.1. Knife Handles and Blades Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.1.3. Scissors
- 4.5.1.3.1. Scissors Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.1.4. Needle Holders
- 4.5.1.4.1. Needle Holders Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.1.5. Clamps
- 4.5.1.5.1. Clamps Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.1.6. Hooks and Retractors
- 4.5.1.6.1. Hooks and Retractors Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.1.7. Others
- 4.5.1.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.6. Implants & Grafts
- 4.6.1. Implants & Grafts Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.7. Equipment
- 4.7.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 5. Oculoplastic Surgery Market: Procedure Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Oculoplastic Surgery Market: Procedure Movement Analysis
- 5.3. Oculoplastic Surgery Market by Procedure Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. Eyelid Surgery
- 5.5.1. Eyelid Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.6. Facelift
- 5.6.1. Facelift Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.7. Brow Lift/ Forehead lift
- 5.7.1. Brow Lift/ Forehead lift Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.8. Pediatric Oculoplastic Surgery
- 5.8.1. Pediatric Oculoplastic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.9. Orbital Surgery
- 5.9.1. Orbital Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Oculoplastic Surgery Market: End-use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Oculoplastic Surgery Market: End-use Movement Analysis
- 6.3. Oculoplastic Surgery Market by End-use Outlook (USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5. Hospitals and clinics
- 6.5.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6. Ambulatory Surgical Centers
- 6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Oculoplastic Surgery Market: Regional Estimates & Trend Analysis
- 7.1. Regional Dashboard
- 7.2. Regional Chapter Oculoplastic Surgery Market movement analysis
- 7.3. Oculoplastic Surgery Market: Regional Estimates & Trend Analysis by Product, Procedure and Material Product
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.5. North America
- 7.5.1. North Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Reimbursement scenario
- 7.5.2.5. U.S. Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Reimbursement scenario
- 7.5.3.5. Canada Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. Europe
- 7.5.5. Europe Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. UK
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Competitive Scenario
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Reimbursement scenario
- 7.5.6.5. UK Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Germany
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. Reimbursement scenario
- 7.5.7.5. Germany Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.8. France
- 7.5.8.1. Key Country Dynamics
- 7.5.8.2. Competitive Scenario
- 7.5.8.3. Regulatory Framework
- 7.5.8.4. Reimbursement scenario
- 7.5.8.5. France Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.9. Italy
- 7.5.9.1. Key Country Dynamics
- 7.5.9.2. Competitive Scenario
- 7.5.9.3. Regulatory Framework
- 7.5.9.4. Reimbursement scenario
- 7.5.9.5. Italy Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.10. Spain
- 7.5.10.1. Key Country Dynamics
- 7.5.10.2. Competitive Scenario
- 7.5.10.3. Regulatory Framework
- 7.5.10.4. Reimbursement scenario
- 7.5.10.5. Spain Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.11. Denmark
- 7.5.11.1. Key Country Dynamics
- 7.5.11.2. Competitive Scenario
- 7.5.11.3. Regulatory Framework
- 7.5.11.4. Reimbursement scenario
- 7.5.11.5. Denmark Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.12. Sweden
- 7.5.12.1. Key Country Dynamics
- 7.5.12.2. Competitive Scenario
- 7.5.12.3. Regulatory Framework
- 7.5.12.4. Reimbursement scenario
- 7.5.12.5. Sweden Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.13. Norway
- 7.5.13.1. Key Country Dynamics
- 7.5.13.2. Competitive Scenario
- 7.5.13.3. Regulatory Framework
- 7.5.13.4. Reimbursement scenario
- 7.5.13.5. Norway Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Asia Pacific Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Japan
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Reimbursement scenario
- 7.6.2.5. Japan Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. China
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Reimbursement scenario
- 7.6.3.5. China Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. India
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. Reimbursement scenario
- 7.6.4.5. India Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. South Korea
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Reimbursement scenario
- 7.6.5.5. South Korea Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.6. Australia
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Competitive Scenario
- 7.6.6.3. Regulatory Framework
- 7.6.6.4. Reimbursement scenario
- 7.6.6.5. Australia Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.7. Thailand
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Competitive Scenario
- 7.6.7.3. Regulatory Framework
- 7.6.7.4. Reimbursement scenario
- 7.6.7.5. Thailand Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7. Latin America
- 7.7.1. Latin America Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Brazil
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. Reimbursement scenario
- 7.7.2.5. Brazil Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Mexico
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Reimbursement scenario
- 7.7.3.5. Mexico Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.4. Argentina
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. Reimbursement scenario
- 7.7.4.5. Argentina Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8. Middle East & Africa
- 7.8.1. Middle East & Africa Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.2. South Africa
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory Framework
- 7.8.2.4. Reimbursement scenario
- 7.8.2.5. South Africa Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Saudi Arabia
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory Framework
- 7.8.3.4. Reimbursement scenario
- 7.8.3.5. Saudi Arabia Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.4. UAE
- 7.8.4.1. Key Country Dynamics
- 7.8.4.2. Competitive Scenario
- 7.8.4.3. Regulatory Framework
- 7.8.4.4. Reimbursement scenario
- 7.8.4.5. UAE Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.5. Kuwait
- 7.8.5.1. Key Country Dynamics
- 7.8.5.2. Competitive Scenario
- 7.8.5.3. Regulatory Framework
- 7.8.5.4. Reimbursement scenario
- 7.8.5.5. Kuwait Oculoplastic Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Market Participant Categorization
- 8.2. Key Company Profiles
- 8.2.1. Surgical Holdings
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Product benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. Matrix Surgical USA
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Product benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. Integra LifeSciences Corporation
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. Stryker
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. FCI
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. Bolton Surgical Ltd.
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. RUMEX International Co.
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. BVI Medical.
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Product benchmarking
- 8.2.8.4. Strategic initiatives
- 8.2.9. Carl Zeiss Meditec AG
- 8.2.9.1. Company overview
- 8.2.9.2. Financial performance
- 8.2.9.3. Product benchmarking
- 8.2.9.4. Strategic initiatives
- 8.2.10. Bausch + Lomb
- 8.2.10.1. Company overview
- 8.2.10.2. Financial performance
- 8.2.10.3. Product benchmarking
- 8.2.10.4. Strategic initiatives
°ü·ÃÀÚ·á